Back to JANE STREET GROUP, LLC JANE STREET GROUP, LLC

LIMNLIMN
4 quarters

Position history for JANE STREET GROUP, LLCJANE STREET GROUP, LLC's holdings in LIMINATUS PHARMA INC.

No. Jane Street Group exited its LIMN (Liminatus Pharma) position in Q2 2026. Its Q1 2026 13F listed 71,318 shares worth $12,259. Jane Street Group first reported LIMN in Q3 2025 and held it in 2 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$66,190

Total Shares Change

-39,635

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$5.50
0
2026-Q1
New
71,318
-
$12,2590.0%$8.60
27
2025-Q4
Exited
0
-100.0%
$00.0%$30.50
0
2025-Q3
New
39,635
-
$66,1900.0%$83.50
32

Other major holders of LIMN: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, STATE STREET CORP, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used